Navigate to Other Sector


Healthcare Newsletter – September 2017

Novartis’s Kymriah Marks a New Era in Futuristic Medicine
Expanding Global Access for Biosimilars
Abbott Pulls the Plug on Bio-absorbable Stents
Quality Threats Extending Beyond the world of Small Molecule Drugs
Pharma, MedTech, Services –Global M&A Round up for the Month
Continuing Lure of Co-Marketing Business Models in Difficult-to-access Markets

Contact us to know more…

Discussion — No responses

Show Buttons
Hide Buttons